Advertisement
Advertisement

CNTX

CNTX logo

Context Therapeutics Inc. Common Stock

2.28
USD
Sponsored
+0.02
+0.71%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

2.27

-0.01
-0.48%

CNTX Earnings Reports

Positive Surprise Ratio

CNTX beat 8 of 15 last estimates.

53%

Next Report

Date of Next Report
Mar 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.10
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q4 24 (Revenue/ EPS)
--
/
+150.00%

Context Therapeutics Inc. Common Stock earnings per share and revenue

On Nov 05, 2025, CNTX reported earnings of -0.10 USD per share (EPS) for Q3 25, missing the estimate of -0.09 USD, resulting in a -4.06% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -5.31% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.10 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Context Therapeutics Inc. Common Stock reported EPS of -$0.10, missing estimates by -4.06%, and revenue of $0.00, 0% as expectations.
The stock price moved down -5.31%, changed from $1.13 before the earnings release to $1.07 the day after.
The next earning report is scheduled for Mar 12, 2026.
Based on 11 analysts, Context Therapeutics Inc. Common Stock is expected to report EPS of -$0.10 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement